Your browser doesn't support javascript.
loading
Targeting AMPK, mTOR and ß-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients.
Abdelmonsif, Doaa Ali; Sultan, Ahmed S; El-Hadidy, Wessam F; Abdallah, Dina Mohamed.
Afiliação
  • Abdelmonsif DA; Department of Medical Biochemistry, Faculty of Medicine, Alexandria University, Alexandria, Egypt. doaa.elmonsif@alexmed.edu.eg.
  • Sultan AS; Molecular Biology and Nanomedicine Laboratories, Centre of Excellence for Regenerative Medicine Research and Applications, Faculty of Medicine, Alexandria University, Alexandria, Egypt. doaa.elmonsif@alexmed.edu.eg.
  • El-Hadidy WF; Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria, Egypt.
  • Abdallah DM; Department of Pharmacology and Experimental Therapeutics, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Mol Diagn Ther ; 22(1): 115-127, 2018 02.
Article em En | MEDLINE | ID: mdl-29094287

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aspirina / Carcinoma Hepatocelular / Beta Catenina / Proteínas Quinases Ativadas por AMP / Serina-Treonina Quinases TOR / Neoplasias Hepáticas / Metformina Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aspirina / Carcinoma Hepatocelular / Beta Catenina / Proteínas Quinases Ativadas por AMP / Serina-Treonina Quinases TOR / Neoplasias Hepáticas / Metformina Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article